A significant breakthrough in medical science has been reported by UK doctors in the treatment of Huntington’s disease, a devastating and currently incurable genetic condition. A team of researchers delivered a new gene therapy that was found to slow the progression of the deadly disorder by approximately 75% in clinical trials on human patients. This advance, achieved after decades of research, offers new hope for those afflicted and represents one of the year’s most important developments in cellular and neurobiology.
